AN2 Therapeutics, Inc., (ANTX): Price and Financial Metrics Recent IPO


AN2 Therapeutics, Inc., (ANTX): $7.91

-0.23 (-2.83%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ANTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

ANTX Stock Price Chart Interactive Chart >

Price chart for ANTX

ANTX Price/Volume Stats

Current price $7.91 52-week high $23.58
Prev. close $8.14 52-week low $7.43
Day low $7.81 Volume 47,719
Day high $8.83 Avg. volume 79,713
50-day MA $13.01 Dividend yield N/A
200-day MA $0.00 Market Cap 153.48M

AN2 Therapeutics, Inc., (ANTX) Company Bio


AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.


ANTX Latest News Stream


Event/Time News Detail
Loading, please wait...

ANTX Latest Social Stream


Loading social stream, please wait...

View Full ANTX Social Stream

ANTX Price Returns

1-mo N/A
3-mo -47.51%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.0501 seconds.